Laser Capture Microdissection Market: Overview
Laser capture microdissection (LCM) technology is a contamination free procedure for obtaining subpopulations of tissue cells under direct microscopic visualization. Furthermore, laser-capture microdissection technology isolates specific cells by dissecting unwanted cells. Laser capture microdissection technology harvests the cells of interest directly to give pure enriched cells. This technology helps in preserving the genuine morphology of the dissected cell or tissue sample. The laser capture microdissection technology by type can be segmented into software, instruments, consumables, and services. Furthermore, the market for laser capture microdissection by system can be segmented into infrared LCM, ultraviolet LCM and Immunofluorescence LCM. In addition, by end users the laser capture microdissection market can be segmented into biotechnology and pharmaceutical companies, hospitals and government research institutes among others. Moreover, by application the market can be segmented into research and development and diagnostics among others.
View Report : https://www.transparencymarketresearch.com/laser-capture-microdissection-market.html
The laser capture microdissection market by geography has been segmented into Europe, Asia Pacific, North America and Rest of the World (RoW).
Laser Capture Microdissection Market: Trends and Opportunities
Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level. In addition, growing funding and expenditure on research and development activities of companies involved in this market is stimulating the growth of this market. High maintenance and manufacturing cost of accessories and equipment along with lack of expertise professionals in this field is some of the restraining factors which may hinder the growth of this market.
Research and development and diagnostics among others are major application areas of laser-capture microdissection technology. Furthermore, government research institutes and hospitals are major end users of this technology. Moreover, ultraviolet LCM and infrared LCM are leading the market globally. Increasing preference of laser-capture microdissection technology in forensic science and molecular biology under the research and development application segment is one of the major driving factors for the market.
Laser Capture Microdissection Market: Geographical and Competitive Dynamics
With the increasing technological advancement and growing application of laser-capture microdissection (LCM) technology in pharmaceuticals, hospitals and research and development institutes are fueling the market globally. North America dominated the market for laser-capture microdissection in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Moreover, with the increasing expenditure on research and development activities of companies dealing in this market along with increasing awareness regarding the technological advancement is driving the market for laser-capture microdissection across Asia Pacific. China, Japan, India, contributes in the positive growth of this market across Asia Pacific. Growing application areas of this technology in the fields such as forensic science, diagnostics and molecular biology are having a positive impact on the growing market for laser-capture microdissection in Rest of the World (RoW).
For More Details, Request A PDF Brochure Report @
Some of the key players operating in the laser capture microdissection market are Carl Zeiss AG (Germany), Molecular Machines & Industries (Germany), Ocimum Biosolutions LLC (U.S.), DeNova Sciences Pte. Ltd. (Singapore), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Indivumed GmbH (Germany), AvanSci Bio, L.L.C. (U.S.), Theranostics Health, Inc.(U.S.) and 3DHISTECH Ltd. (Hungary) among others.